Publications
805
Citations
62,699
Est. group size
—
Recurring co-author estimate
Active years
42
Publishing since 1984
Martin R. Farlow studies Alzheimer's disease and related forms of dementia, with a particular focus on inherited (autosomal-dominant) early-onset Alzheimer's and its progression. The work spans clinical trials of experimental drugs, brain imaging and biological markers of disease, and molecular studies of how the disease develops in the brain. Much of this research is part of large collaborative networks tracking patients over many years.
Publication activity has been consistently high throughout the last decade, though the counts for the most recent years may be incomplete.
Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026
- Cortical asymmetry in autosomal dominant Alzheimer’s disease progression
Brain Communications · 2025
- Regional effects of gantenerumab on neuroimaging biomarkers in the DIAN‐TU‐001 trial
Alzheimer s & Dementia · 2025
- Systematic analysis of cellular cross-talk reveals a role for SEMA6D-TREM2 regulating microglial function in Alzheimer’s disease
Science Translational Medicine · 2025
- The landscape of autosomal-dominant Alzheimer’s disease: global distribution and age of onset
Brain · 2025
- A multicenter, randomized, double-blind, placebo-controlled ascending dose study to evaluate the safety, tolerability, pharmacokinetics (PK) and pharmacodynamic (PD) effects of Posiphen in subjects with Early Alzheimer’s Disease
medRxiv · 2024
- 15 Years of Longitudinal Genetic, Clinical, Cognitive, Imaging, and Biochemical Measures in DIAN
medRxiv · 2024
- Brain Volumetric Trajectories in Down Syndrome and Autosomal Dominant Alzheimer Disease
Alzheimer s & Dementia · 2024
- Results of SIGNAL‐AD, a randomized, phase 1b/2 trial to evaluate safety and efficacy of targeting reactive astrocytes with pepinemab, SEMA4D blocking antibody, in people with mild Alzheimer’s dementia
Alzheimer s & Dementia · 2024
- Sex Differences in Basal Cortisol Levels Across Body Fluid Compartments in a Cross-sectional Study of Healthy Adults
Journal of the Endocrine Society · 2024
- A Protocol for the Inclusion of Minoritized Persons in Alzheimer Disease Research From the ADNI3 Diversity Taskforce
JAMA Network Open · 2024
- Molecular neuroimaging in dominantly inherited versus sporadic early-onset Alzheimer’s disease
Brain Communications · 2024
- γ-Secretase activity, clinical features, and biomarkers of autosomal dominant Alzheimer's disease: cross-sectional and longitudinal analysis of the Dominantly Inherited Alzheimer Network observational study (DIAN-OBS)
The Lancet Neurology · 2024
- Downstream Biomarker Effects of Gantenerumab or Solanezumab in Dominantly Inherited Alzheimer Disease
JAMA Neurology · 2024
- Changes in cortical thickness along the Alzheimer disease continuum in people with Down syndrome
Alzheimer s & Dementia · 2023
- Functional variations in gamma‐secretase processing of APP are critical determinants of the clinical, biomarker, and cognitive progression of autosomal dominant Alzheimer’s disease
Alzheimer s & Dementia · 2023
- Alzheimer s & Dementia×95
- medRxiv×15
- PMC×10
- Nature Communications×9
- Brain×8
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 11, 2026.
Claim or correct this profile